Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Other Working Capital Changes (2016 - 2025)

Anaptysbio's Other Working Capital Changes history spans 10 years, with the latest figure at -$494000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 73.77% year-over-year to -$494000.0; the TTM value through Dec 2025 reached -$1.9 million, up 39.9%, while the annual FY2025 figure was -$1.9 million, 39.9% up from the prior year.
  • Other Working Capital Changes reached -$494000.0 in Q4 2025 per ANAB's latest filing, down from -$490000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $5.4 million in Q4 2023 to a low of -$6.7 million in Q4 2021.
  • Average Other Working Capital Changes over 5 years is $84000.0, with a median of -$435000.0 recorded in 2023.
  • The largest YoY upside for Other Working Capital Changes was 3170.59% in 2024 against a maximum downside of 225.84% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$6.7 million in 2021, then surged by 74.7% to -$1.7 million in 2022, then surged by 417.3% to $5.4 million in 2023, then crashed by 134.81% to -$1.9 million in 2024, then soared by 73.77% to -$494000.0 in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Other Working Capital Changes are -$494000.0 (Q4 2025), -$490000.0 (Q3 2025), and -$479000.0 (Q2 2025).